Ajinomoto Cambrooke, Inc.

Founded in 2000, Ajinomoto Cambrooke recognizes the critical nature of managing serious medical disorders through medically based nutrition therapies. For people with serious unmet medical nutrition needs, it is a daily challenge to find flavorful, easy options that can sustain their diets and maintain their nutritional needs. Cambrooke Foods founded by Lynn and David Paolella.

Founded in 2000, Cambrooke, a proud member of The Ajinomoto Group, is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com

Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs.

CAMINO PRO® Amino Acid metabolic formula products introduced.

Cambrooke introduces the DietWell™ for PKU app for the iPhone®, iPod touch®, and iPad® - designed to assist families and individuals in the dietary management of Phenylketonuria (PKU).

BetterMilk the first Glytactin with GMP product introduced.

Cambrooke Foods expands, launching Cambrooke Therapeutics.

Tylactin RTD and Tylactin Restore, the first metabolic formulas for the dietary management of Tyrosinemia containing a natural protein (GMP) are introduced.

KetoVie™, the advanced liquid ketogenic medical food is introduced.

Glytactin Build™, the lowest calorie GMP-based formula is introduced. Expansion of KetoVie Café line of low-carbohydrate, convenient, ketogenic friendly foods.

Acquired by Ajinomoto North America, Inc., a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals.

Cambrooke Therapeutics annnounces the corporate name change to Ajinomoto Cambrooke, Inc. The name change to Ajinomoto Cambrooke reflects the benefits Ajinomoto Co. helps us bring to our customers.

Cambrooke Therapeutics and Trovita Health Science Announce Strategic Alliance for ENU® Nutrition meal replacement shakes. ENU nutrition products were developed in collaboration with registered dietitians from leading academic and community cancer centers in the United States to help those seeking a highly nutritious, more natural, non-GMO nutrition supplement drink.

Acquired Nualtra in December of 2020 as they aimed to create better value for the healthcare systems in the UK & Ireland through introducing more cost-effective medical nutrition and better lives for patients by developing better tasting supplements to improve their experience of ONS (Oral Nutritional Supplements).

Pioneers as the first amino acid-based formula with no corn syrup solids and all natural and low FODMAP ingredients in Essential Care Jr.™ and a lower costing EquaCare Jr.® that is similar in nutrition and taste to other amino acid-based formulas that are Essentially Better for the GI/allergy patients.